Jankowitz RC - Search Results

1

Should we embrace or ablate our urge to (ovarian) suppress?

Jankowitz RC, Puhalla S, Davidson NE. Jankowitz RC, et al. J Clin Oncol. 2014 Dec 10;32(35):3920-2. doi: 10.1200/JCO.2014.57.9953. Epub 2014 Nov 3. J Clin Oncol. 2014. PMID: 25366692 No abstract available.

2

Adjuvant endocrine therapy for breast cancer: don't ditch the switch!

Puhalla S, Jankowitz RC, Davidson NE. Puhalla S, et al. Among authors: jankowitz rc. J Natl Cancer Inst. 2011 Sep 7;103(17):1280-2. doi: 10.1093/jnci/djr302. Epub 2011 Aug 22. J Natl Cancer Inst. 2011. PMID: 21859987 No abstract available.

3

Epigenetics in breast cancer: what's new?

Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S. Huang Y, et al. Breast Cancer Res. 2011;13(6):225. doi: 10.1186/bcr2925. Epub 2011 Nov 1. Breast Cancer Res. 2011. PMID: 22078060 Free PMC article. Review.

4

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.

Klein ME, Dabbs DJ, Shuai Y, Brufsky AM, Jankowitz R, Puhalla SL, Bhargava R. Klein ME, et al. Mod Pathol. 2013 May;26(5):658-64. doi: 10.1038/modpathol.2013.36. Epub 2013 Mar 15. Mod Pathol. 2013. PMID: 23503643 Free PMC article.

5

Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.

Jankowitz RC, McGuire KP, Davidson NE. Jankowitz RC, et al. Breast. 2013 Aug;22 Suppl 2:S165-70. doi: 10.1016/j.breast.2013.07.032. Breast. 2013. PMID: 24074781 Free article. Review.

6

Adjuvant endocrine therapy for breast cancer: how long is long enough?

Jankowitz RC, Davidson NE. Jankowitz RC, et al. Oncology (Williston Park). 2013 Dec;27(12):1210-6, 1224. Oncology (Williston Park). 2013. PMID: 24624537 Free article. Review.

7

Epigenetic reprogramming in breast cancer: from new targets to new therapies.

Katz TA, Huang Y, Davidson NE, Jankowitz RC. Katz TA, et al. Among authors: jankowitz rc. Ann Med. 2014 Sep;46(6):397-408. doi: 10.3109/07853890.2014.923740. Epub 2014 Jul 24. Ann Med. 2014. PMID: 25058177 Free article.

8

Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial.

Greenspan SL, Vujevich KT, Brufsky A, Lembersky BC, van Londen GJ, Jankowitz RC, Puhalla SL, Rastogi P, Perera S. Greenspan SL, et al. Among authors: jankowitz rc. Osteoporos Int. 2015 Jun;26(6):1857-64. doi: 10.1007/s00198-015-3100-7. Epub 2015 Mar 20. Osteoporos Int. 2015. PMID: 25792492 Free PMC article. Clinical Trial.

9

Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trial.

Prasad C, Greenspan SL, Vujevich KT, Brufsky A, Lembersky BC, van Londen GJ, Jankowitz RC, Puhalla SL, Rastogi P, Perera S. Prasad C, et al. Among authors: jankowitz rc. Bone. 2016 Sep;90:123-6. doi: 10.1016/j.bone.2016.03.010. Epub 2016 Mar 24. Bone. 2016. PMID: 27018037 Clinical Trial.

10

New Strategies in Metastatic Hormone Receptor-Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies.

Jankowitz RC, Oesterreich S, Lee AV, Davidson NE. Jankowitz RC, et al. Clin Cancer Res. 2017 Mar 1;23(5):1126-1131. doi: 10.1158/1078-0432.CCR-16-0591. Epub 2016 Dec 15. Clin Cancer Res. 2017. PMID: 27979914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters